This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Stanford Graduate School of Business (USA)
-
How Stories Drive Growth: HSN
Aaker, J; Schifrin, DCase SGSB-M348B-EMarketingStories play an important role in business. They are a powerful tool for persuasion and useful in the context of understanding customers, building brands and leading teams. Set in 2014, the case explores how stories can drive the growth of a company, focusing on HSN Inc., the $3 billion interactive, multi-channel retailer. When Mindy Grossman became CEO of HSN in 2006, she had three major challenges: create a new story for a 30-year old company t...Starting at €8.20
-
Atmel: Igniting the B2c in B2B
Shiv, B; Hoyt, DCase SGSB-M360-EMarketingAtmel Corporation is a manufacturer of semiconductors (chips). It is an engineering-driven business-to-business company, and prior to 2012 its marketing was largely limited to preparation of specifications, launching new products, and trade shows. In 2012, it hired Sander Arts as Vice President of Marketing. Arts was not an engineer, and had very different ideas about how marketing could add value to the company. For instance, he believed tha...Starting at €8.20
-
Atmel: Igniting the B2C in B2B -Teaching Note
Shiv, Baba; Hoyt, DavidTeaching Note SGSB-M360TN-EMarketingAtmel Corporation is a manufacturer of semiconductors (chips). It is an engineering-driven business-to-business company, and prior to 2012 its marketing was largely limited to preparation of specifications, launching new products, and trade shows. In 2012, it hired Sander Arts as Vice President of Marketing. Arts was not an engineer, and had very different ideas about how marketing could add value to the company. For instance, he believed tha...Starting at €0.00
-
Amir Dan Rubin: Success from the Beginning
Pfeffer, JCase SGSB-OB90-ECorporate Governance, StrategyIn November of 2010, the board of Stanford Hospital and Clinics announced that Amir Dan Rubin, at the time chief operating officer of the UCLA Hospital System, would become the next CEO at Stanford Hospital and Clinics. Although by 2010 Stanford hospital had largely recovered from a failed merger with the hospital of the University of California, San Francisco, and was financially stable, Rubin would lead an organization that still faced signifi...Starting at €8.20
-
Landlocked Homes: Catching a Falling Knife
Abbey, D; Mahowald, C; Lamont, MCase SGSB-RE137-EStrategyWhen Jacob Harold became head of the Hewlett Foundation’s Philanthropy Program, he began to see GuideStar as much more than just a website. GuideStar was the result of founder Arthur “Buzz” Schmidt’s vision of bringing transparency and accountability to the world of nonprofits. At its core, the organization compiled information that U.S. nonprofits submitted on their IRS filings into an easy to use database. It supplemented that information wi...Starting at €8.20
-
TTTech (C ): Hitting the Gas Pedal
Siegel RCase SGSB-SM185C-EStrategyTo be used in conjunction with the (A) and (B) cases, keeping the students current on the status of the firm.Starting at €8.20
-
Health Leads (A): Expansion Decisions for a Health Care Nonprofit
Sorensen J; Schifrin D; Hettrich KCase SGSB-SM192A-EStrategyThe (A) case presents a 2009 critical expansion decision for health care nonprofit Health Leads: whether to expand rapidly while it had momentum, strong advocates, very high demand for its services, and funder support for growth; or whether to postpone rapid expansion and continue working on its model and further prove the company’s value to hospitals and clinics. Founded by Rebecca Onie (2009 MacArthur “Genius Grant” Fellow), Health Leads addre...Starting at €8.20
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Waste Management's Organic Growth Group
Burgelman, R; Siegel, R; Uribe, TCase SGSB-SM210-EStrategyIt was 2005 and David Steiner, CEO of Waste Management (WM), had just received a report from an internal advisory panel created some months before to assess the future of the waste management industry and propose how the company’s strategy should be adapted. The core of this report was the recommendation to create a special unit within the company, chartered with the central purpose of identifying ways to extract value from waste through new and ...Starting at €8.20